Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-52

2 Aug 22. First Patient Recruited to ACCENT Trial in Pancreatic Cancer

29 Nov 22. ACCENT Trial Recruitment Progress

11 Jan 23. Dose Escalation Approved in ACCENT Clinical Trial of AMP945

28 Feb 23. ACCENT Trial Recruitment Progress

19 April 23. First Patient Recruited to Cohort 3 of ACCENT Trial in Pancreatic Cancer

9 May 23 ACCENT Trial Recruitment Progress

2 Aug 23. ACCENT Trial Recruitment Update

30 Nov 23. AMPLIA REPORTS PROMISING CLINICAL DATA
FROM PHASE 1B PORTION OF THE ACCENT TRIAL IN PANCREATIC CANCER

Love the 30th Nov update …

So yes, there has been plenty of updates along the way.

Reading through some of these announcements theres not been any suggestion of any difficulty recruiting patients.

Hopefully as we progress there will be more updates of what’s happening both here and Korea

.

.